@article{YaoubaKochGuantaietal.2018, author = {Yaouba, Souaibou and Koch, Andreas and Guantai, Eric M. and Derese, Solomon and Irungu, Beatrice and Heydenreich, Matthias and Yenesew, Abiy}, title = {Alkenyl cyclohexanone derivatives from Lannea rivae and Lannea schweinfurthii}, series = {Phytochemistry letters / Phytochemical Society of Europe}, volume = {23}, journal = {Phytochemistry letters / Phytochemical Society of Europe}, publisher = {Elsevier}, address = {Amsterdam}, issn = {1874-3900}, doi = {10.1016/j.phytol.2017.12.001}, pages = {141 -- 148}, year = {2018}, abstract = {Phytochemical investigation of the CH2Cl2/MeOH (1:1) extract of the roots of Lannea rivae (Chiov) Sacleux (Anacardiaceae) led to the isolation of a new alkenyl cyclohexenone derivative: (4R,6S)-4,6-dihydroxy-6-((Z)-nonadec-14′-en-1-yl)cyclohex-2-en-1-one (1), and a new alkenyl cyclohexanol derivative: (2S*,4R*,5S*)-2,4,5-trihydroxy-2-((Z)-nonadec-14′-en-1-yl)cyclohexanone (2) along with four known compounds, namely epicatechin gallate, taraxerol, taraxerone and β-sitosterol; while the stem bark afforded two known compounds, daucosterol and lupeol. Similar investigation of the roots of Lannea schweinfurthii (Engl.) Engl. led to the isolation of four known compounds: 3-((E)-nonadec-16′-enyl)phenol, 1-((E)-heptadec-14′-enyl)cyclohex-4-ene-1,3-diol, catechin, and 1-((E)-pentadec-12′-enyl)cyclohex-4-ene-1,3-diol. The structures of the isolated compounds were determined by NMR spectroscopy and mass spectrometry. The absolute configuration of compound 1 was established by quantum chemical ECD calculations. In an antibacterial activity assay using the microbroth kinetic method, compound 1 showed moderate activity against Escherichia coli while compound 2 exhibited moderate activity against Staphylococcus aureus. Compound 1 also showed moderate activity against E. coli using the disc diffusion method. The roots extract of L. rivae was notably cytotoxic against both the DU-145 prostate cancer cell line and the Vero mammalian cell line (CC50 = 5.24 and 5.20 μg/mL, respectively). Compound 1 was also strongly cytotoxic against the DU-145 cell line (CC50 = 0.55 μg/mL) but showed no observable cytotoxicity (CC50 > 100 μg/mL) against the Vero cell line. The roots extract of L. rivae and L. schweinfurthii, epicatechin gallate as well as compound 1 exhibited inhibition of carageenan-induced inflammation.}, language = {en} } @article{IrunguAdipoOrwaetal.2015, author = {Irungu, Beatrice N. and Adipo, Nicholas and Orwa, Jennifer A. and Kimani, Francis and Heydenreich, Matthias and Midiwo, Jacob O. and Bjoremark, Per Martin and Hakansson, Mikael and Yenesew, Abiy and Erdelyi, Mate}, title = {Antiplasmodial and cytotoxic activities of the constituents of Turraea robusta and Turraea nilotica}, series = {Journal of ethnopharmacology : an interdisciplinary journal devoted to bioscientific research on indigenous drugs}, volume = {174}, journal = {Journal of ethnopharmacology : an interdisciplinary journal devoted to bioscientific research on indigenous drugs}, publisher = {Elsevier}, address = {Clare}, issn = {0378-8741}, doi = {10.1016/j.jep.2015.08.039}, pages = {419 -- 425}, year = {2015}, abstract = {Ethnopharmacological relevance: Turraea robusta and Turraea nilotica are African medicinal plants used for the treatment of a wide variety of diseases, including malaria. The genus Turraea is rich in limonoids and other triterpenoids known to possess various biological activities. Materials and methods: From the stem bark of T. robusta six compounds, and from various parts of T nilotica eleven compounds were isolated by the use of a combination of chromatographic techniques. The structures of the isolated compounds were elucidated using NMR and MS, whilst the relative configuration of one of the isolated compounds, toonapubesin F, was established by X-ray crystallography. The antiplasmodial activities of the crude extracts and the isolated constituents against the D6 and W2 strains of Plasmodium falciparum were determined using the semiautomated micro dilution technique that measures the ability of the extracts to inhibit the incorporation of (G-H-3, where G is guanine) hypoxanthine into the malaria parasite. The cytotoxicity of the crude extracts and their isolated constituents was evaluated against the mammalian cell lines African monkey kidney (vero), mouse breast cancer (4T1) and human larynx carcinoma (HEp2). Results: The extracts showed good to moderate antiplasmodial activities, where the extract of the stem bark of T. robusta was also cytotoxic against the 4T1 and the HEp2 cells (IC50 < 10 mu g/ml). The compounds isolated from these extracts were characterized as limonoids, protolimonoids and phytosterol glucosides. These compounds showed good to moderate activities with the most active one being azadironolide, IC50 2.4 +/- 0.03 mu M and 1.1 +/- 0.01 mu M against the D6 and W2 strains of Plasmodium falciparum, respectively; all other compounds possessed IC50 14.4-40.5 mu M. None of the compounds showed significant cytotoxicity against vero cells, yet four of them were toxic against the 4T1 and HEp2 cancer cell lines with piscidinol A having IC50 8.0 +/- 0.03 and 8.4 +/- 0.01 mu M against the 4T1 and HEp2 cells, respectively. Diacetylation of piscidinol A resulted in reduced cytotoxicity. Conclusion: From the medicinal plants T. robusta and T. nilotica, twelve compounds were isolated and characterized; two of the isolated compounds, namely 11-epi-toonacilin and azadironolide showed good antiplasmodial activity with the highest selectivity indices. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.}, language = {en} } @article{MarcoDeyouGruhonjicetal.2017, author = {Marco, Makungu and Deyou, Tsegaye and Gruhonjic, Amra and Holleran, John and Duffy, Sandra and Heydenreich, Matthias and Firtzpatrick, Paul A. and Landberg, Goran and Koch, Andreas and Derese, Solomon and Pelletier, Jerry and Avery, Vicky M. and Erdelyi, Mate and Yenesew, Abiy}, title = {Pterocarpans and isoflavones from the root bark of Millettia micans and of Millettia dura}, series = {Phytochemistry letters}, volume = {21}, journal = {Phytochemistry letters}, publisher = {Elsevier}, address = {Amsterdam}, issn = {1874-3900}, doi = {10.1016/j.phytol.2017.07.012}, pages = {216 -- 220}, year = {2017}, language = {en} } @article{AbdissaHeydenreichMidiwoetal.2014, author = {Abdissa, Negera and Heydenreich, Matthias and Midiwo, Jacob O. and Ndakala, Albert and Majer, Zsuzsanna and Neumann, Beate and Stammler, Hans-Georg and Sewald, Norbert and Yenesew, Abiy}, title = {A xanthone and a phenylanthraquinone from the roots of Bulbine frutescens, and the revision of six seco-anthraquinones into xanthones}, series = {Phytochemistry letters}, volume = {9}, journal = {Phytochemistry letters}, publisher = {Elsevier}, address = {Amsterdam}, issn = {1874-3900}, doi = {10.1016/j.phytol.2014.04.004}, pages = {67 -- 73}, year = {2014}, abstract = {Phytochemical investigation of the dichloromethane/methanol (1:1) extract of the roots of Bulbine frutescens led to the isolation of a new xanthone, 8-hydroxy-6-methylxanthone-1-carboxylic acid (1) and a new phenylanthraquinone, 6',8-O-dimethylknipholone (2) along with six known compounds. The structures were elucidated on the basis of NMR and MS spectral data analyses. The structure of compound 1 was confirmed through X-ray crystallography which was then used as a reference to propose the revision of the structures of six seco-anthraquinones into xanthones. The isolated compounds were evaluated for cytotoxicity against human cervix carcinoma KB-3-1 cells with the phenylanthraquinone knipholone being the most active (IC50 = 0.43 mu M). Two semi-synthetic knipholone derivatives, knipholone Mannich base and knipholone-1,3-oxazine, were prepared and tested for cytotoxic activity; both showed moderate activities (IC50 value of 1.89 and 2.50 mu M, respectively). (C) 2014 Phytochemical Society of Europe. Published by Elsevier B.V. All rights reserved.}, language = {en} } @article{AdemKueteMbavengetal.2018, author = {Adem, Fozia A. and Kuete, Victor and Mbaveng, Armelle T. and Heydenreich, Matthias and Ndakala, Albert and Irungu, Beatrice and Efferth, Thomas and Yenesew, Abiy}, title = {Cytotoxic benzylbenzofuran derivatives from Dorstenia kameruniana}, series = {Fitoterapia}, volume = {128}, journal = {Fitoterapia}, publisher = {Elsevier}, address = {Amsterdam}, issn = {0367-326X}, doi = {10.1016/j.fitote.2018.04.019}, pages = {26 -- 30}, year = {2018}, abstract = {Chromatographic separation of the extract of the roots of Dorstenia kameruniana (family Moraceae) led to the isolation of three new benzylbenzofuran derivatives, 2-(p-hydroxybenzyl)benzofuran-6-ol (1), 2-(p-hydroxybenzyl)-7-methoxybenzofuran-6-ol (2) and 2-(p-hydroxy)-3-(3-methylbut-2-en-1-yl)benzyl)benzofuran-6-ol (3) (named dorsmerunin A, B and C, respectively), along with the known furanocoumarin, bergapten (4). The twigs of Dorstenia kameruniana also produced compounds 1-4 as well as the known chalcone licoagrochalcone A (5). The structures were elucidated by NMR spectroscopy and mass spectrometry. The isolated compounds displayed cytotoxicity against the sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cells, where compounds 4 and 5 had the highest activities (IC50 values of 7.17 mu M and 5.16 mu M, respectively) against CCRF-CEM leukemia cells. Compound 5 also showed cytotoxicity against 7 sensitive or drug-resistant solid tumor cell lines (breast carcinoma, colon carcinoma, glioblastoma), with IC50 below 50 mu M, whilst 4 showed selective activity.}, language = {en} }